AM Vitals: New Weight–Loss Drug, and Treatment Prospect for Alzheimer's
| FDA Grants Approval to Diet Pill From Vivus (WSJ): Approval of Vivus's weight–loss drug Qsymia marks the second approval of a new weight–loss drug in less than a month; the drugs, which require a doctor's prescription, won't be available until later … See all stories on this topic » |
 Wall Street Journal (blog) |
